Genmab A/S Earning Date (GMAB)

USA |NASDAQ |USD |ADR

GMAB Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 11, 2021 (est) Sep 30, 2021 - $0.07 $0.13
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 11, 2021 (est) Sep 30, 2021 - $1.97B $1.72B

Genmab A/S's next estimated earnings date (based on same quarter last year's date) is Nov 11, 2021 for the fiscal quarter ending Sep 30, 2021.

GMAB Earnings Date & History Chart

GMAB Earnings & Revenue Forecast

GMAB Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $4.55 $4.55 $4.55
Dec 2022 1 $7.61 $7.61 $7.61

GMAB Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $5.28 $5.32 $6.67
Dec 2022 0 / 1 $8.30 $7.79 $7.30

GMAB Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $1.27B $1.16B $1.39B
Dec 2022 7 $1.66B $1.50B $2.04B

GMAB Earnings Date & Revenue History

GMAB Earnings History

|
Show More
Show More

GMAB Revenue History

|
Show More
Show More

Genmab A/S Next Earnings Date & Report

GMAB Aug 2021 (FQ) Earnings Date & Report Preview

GMAB's next estimated earnings date (based on same quarter last year's report date) is Nov 11, 2021 for the fiscal quarter ending Sep 30, 2021.

Genmab A/S Previous Earnings Dates & Reports

GMAB Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Genmab A/S's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.

GMAB's earnings per share (EPS) was $0.07, missing the consensus analysts forecast of $0.99 by -92.57%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by -72.69%, and lower than the same period a year before (Jun 2020) by -94.22%.

Revenues were $1.97B, better than the forecast of $319.59M by 517.05%, up by 24.73% from the previous quarter , and down by -63.82% from the same period last year.

The company reported a net income of $306.00M, -72.08% lower than the previous quarter, and lower by -90.94% than the same period a year before.

Free cash flow for the quarter was $276.00M , compared to $1.16B last quarter and $-184.00M a year before.

GMAB ended the quarter with $443.00M in total debt, an increase of 17.20% compared to the previous quarter, and an increase of 24.44% compared to the same quarter a year before.

GMAB Previous Earnings Date & Report Recap: Dec 2020 (FY)

Genmab A/S's previous annual earnings date was Feb 23, 2021 for its fiscal year ended Dec 31, 2020.

GMAB's earnings per share (EPS) was $9.28, missing the consensus analysts forecast of $11.56 by -19.72% , and higher than the previous year's EPS (Dec 2019) by 72.55%.

Revenues were $10.11B, better than the forecast of $1.62B by 523.83%, and up by 88.43% from previous year's revenue.

The company reported a net income of $4.76B, 119.67% higher than the previous year.

Genmab A/S reported a free cash flow of $6.13B for its fiscal year, compared to $1.22B a year ago.

The company ended the fiscal year with $319.00M in total debt, an increase of 76.24% compared to the previous year.